ImageneBio (IMA) Operating Expenses (2020 - 2025)

ImageneBio has disclosed Operating Expenses across 6 years of filings, most recently posting $26.6 million for Q3 2025.

• Operating Expenses for Q3 2025 came in at $26.6 million, up 380.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $42.1 million (down 34.36% YoY), and the FY2024 annual result was $59.0 million, down 30.27% from the prior year.
• Operating Expenses came in at $26.6 million for Q3 2025 at ImageneBio, up from $8.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $26.6 million in Q3 2025 to a low of $5.5 million in Q3 2024.
• The 5-year median for Operating Expenses is $20.3 million (2022), against an average of $18.0 million.
• Across the five-year window, Operating Expenses slumped 73.24% in 2024 and surged 380.38% in 2025, its largest moves.
• ImageneBio's Operating Expenses stood at $17.4 million in 2021, then rose by 18.01% to $20.6 million in 2022, then grew by 9.74% to $22.6 million in 2023, then rose by 9.08% to $24.6 million in 2024, then grew by 8.04% to $26.6 million in 2025.
• The last three Operating Expenses figures came in at $26.6 million (Q3 2025), $8.8 million (Q2 2025), and $6.8 million (Q1 2025), per Business Quant data.